Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Amantadine | HCID 2130 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | PyBroP | HCID 2733179 | — |
| Reactant | HCID 68466046 | HCID 68466046 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 68469414 | HCID 68469414 | 72.8% |
Reaction Steps
1-[5-(2-Chlorophenyl)-4-methyl-1,2,4-triazol-3-yl]cyclobutanecarboxylic acid (200 mg) was suspended in methylene chloride (7 ml) and then diisopropylethylamine (0.72 ml) and bromotris(pyrrolidino)phosphonium hexafluorophosphate salt (416 mg) were added thereto, followed by stirring at room temperature for 30 minutes. Then, 1-adamantanamine (104 mg) was added to the reaction solution and the whole was stirred at room temperature for 15 hours. The reaction solution was diluted with a saturated aqueous sodium bicarbonate solution (30 ml), followed by extraction with chloroform (20 ml×2). The organic layer was dried over anhydrous sodium sulfate and filtrated and then the solvent was removed by evaporation under reduced pressure. The resulting residue was purified by column chromatography (methanol:chloroform=2:98) and the resulting solid washed with hexane and diethyl ether to obtain 212 mg of N-1-adamantyl-1-[5-(2-chlorophenyl)-4-methyl-1,2,4-triazol-3-yl]cyclobutanecarboxamide (white solid).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07776897B2 |
|---|
| Source dataset | uspto-grants-2010_08 |
|---|
| ORD ID | ord-2e80c2d0aca6479f9b32938c98f950b8 |
|---|
| Source note | uspto-grants-2010_08 |
|---|